
No bio added yet
No link addedCatalysts Successful AI-accelerated drug launches (oncology/immunology) — multi-hundred‑million to multi‑billion revenue impact. AI-enabled companion diagnostics & SaaS — recurring, high-margin revenue and better drug uptake/pricing.Read more
If Australia follows the US e‑commerce trajectory, increased online spending will pressure large physical retailers — Scentre Group’s biggest tenants — reducing footfall, rents and development upside for Westfield malls. That structural shift is the primary long‑term risk to SCG’s income and dividend.Read more